Back to Trades
Fenimore Christopher R.
EVP Finance CFOCIK 0001697422
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Across 2 filings between 2025–2026, Fenimore Christopher R., EVP Finance CFO, has disclosed $20.1M in transactions — all concentrated in REGENERON PHARMACEUTICALS, INC. (REGN). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Aug 20 | REGN REGENERON PHARMACEUTICALS, INC. | Fenimore Christopher R. | EVP Finance CFO | Exercise | $8.5M |
| Dec 9 | REGN REGENERON PHARMACEUTICALS, INC. | Fenimore Christopher R. | EVP Finance CFO | Grant | $11.6M |
2 filings